Shariah compliance overview
Not HalalAkebia Therapeutics, Inc. (AKBA) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Akebia Therapeutics, Inc.
Akebia Therapeutics, Inc., established in 2007 and headquartered in Cambridge, Massachusetts, is a biopharmaceutical company focused on discovering and commercializing therapies for patients suffering from kidney diseases.
Akebia Therapeutics, Inc. (AKBA) operates in the Healthcare sector, in the Biotechnology industry.
Why it is not classified as halal: it does not pass these screens: Interest-bearing debt, Interest-bearing securities and assets.
- Business Activity
- 0.00%Limit 5%Pass
- Interest-bearing debt
- 52.73%Limit 30%Fail
- Interest-bearing securities and assets
- 45.06%Limit 30%Fail
- Dividend purification
- 0.00%Share of dividends to give to charityPurification calculator
Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Akebia Therapeutics, Inc. (AKBA). Current Akinda screening label: Not Halal.
